4.7 Article

Identifying an Immune-Related Gene ST8SIA1 as a Novel Target in Patients With Clear-Cell Renal Cell Carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Robert J. Motzer et al.

Summary: Interim analyses of the IMmotion151 trial showed improved progression-free survival for PD-L1-positive mRCC patients receiving atezolizumab plus bevacizumab vs sunitinib, but final analysis did not show improvement in overall survival. Biomarker analyses provided insight into which mRCC patients may benefit from combined anti-PD-L1 and anti-VEGF therapy.

JAMA ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

Golnaz Morad et al.

Summary: This passage discusses the unprecedented advances in cancer treatment with immune checkpoint blockade (ICB), highlighting the critical need for insights into factors intrinsic and extrinsic to the host that impact ICB response and toxicity. There has been substantial progress in understanding the impact of host-intrinsic factors and the exposome on host physiology and response to treatment, representing the hallmarks of response, resistance, and toxicity to ICB in current day.
Editorial Material Urology & Nephrology

The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care

Jens Bedke et al.

Summary: The recent trials have shown improved survival benefits with immune checkpoint inhibitor combinations in advanced kidney cancer, particularly with lenvatinib plus pembrolizumab, cabozantinib plus nivolumab, axitinib plus pembrolizumab, and ipilimumab plus nivolumab. These combination therapies are recommended as first-line treatments for advanced kidney cancer.

EUROPEAN UROLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Immunology

Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma

Miki Kume et al.

Summary: This study distinguished malignant and benign T cells in CTCL skin lesions and found that benign T cells included limited resident memory T cells (T-RM) with strong antitumor function and showed diminished Th17 property. The high expression of GD3 in malignant T cells was inversely correlated with IL-17A production from benign CD4 T cells, indicating a role of GD3 in suppressing Th17 activity of benign T cells in CTCL independent of T-RM differentiation regulation.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Decreased SPTLC1 expression predicts worse outcomes in ccRCC patients

Wen-Kai Zhu et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2020)

Article Biochemistry & Molecular Biology

TIMER2.0 for analysis of tumor-infiltrating immune cells

Taiwen Li et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Biochemical Research Methods

TISIDB: an integrated repository portal for tumor-immune system interactions

Beibei Ru et al.

BIOINFORMATICS (2019)

Article Urology & Nephrology

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update

Borje Ljungberg et al.

EUROPEAN UROLOGY (2019)

Article Medicine, General & Internal

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Biochemistry & Molecular Biology

CancerSEA: a cancer single-cell state atlas

Huating Yuan et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biochemistry & Molecular Biology

LinkedOmics: analyzing multi-omics data within and across 32 cancer types

Suhas V. Vasaikar et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

Review Pharmacology & Pharmacy

Ganglioside GD3 synthase (GD3S), a novel cancer drug target

Jinyi Liu et al.

ACTA PHARMACEUTICA SINICA B (2018)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Biochemistry & Molecular Biology

An Immune Atlas of Clear Cell Renal Cell Carcinoma

Stephane Chevrier et al.

Article Urology & Nephrology

Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma

Timothy J. Williamson et al.

BJU INTERNATIONAL (2016)

Article Multidisciplinary Sciences

Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity

Shih-Chi Yeh et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Biochemistry & Molecular Biology

GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer

T. R. Sarkar et al.

ONCOGENE (2015)

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Article Biochemistry & Molecular Biology

Expression of the human CMP-NeuAc:GM3 α2,8-sialyltransferase (GD3 synthase) gene through the NF-κB activation in human melanoma SK-MEL-2 cells

Nam-Young Kang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2007)